Saturday, December 4, 2021

TAG

Bharat Biotech

Covaxin maker laments “fake news”, has hit our morale

Ahead of the World Health Organisation’s technical advisory group meet to consider emergency use listing of India’s indigenous Covid vaccine Covaxin, Bharat Biotech founder...

Call on Covaxin by WHO on October 26: Swaminathan

World Health Organisation chief scientist Soumya Swaminathan has informed that the technical advisory group examining the vaccine would meet on October 26 to consider...

Decision on Covaxin approval no later than October, says WHO

The World Health Organization has declared that it would decide on the inclusion of Covaxin in its Emergency Use Listing no later than October.  The...

Covaxin gets approval from Hungary; Bharat Biotech says only the Ist step

In a big boost, Bharat Biotech's Covid-19 vaccine Covaxin has received Good Manufacturing Practices (GMP) compliance certificate from Hungary. Bharat Biotech took to Twitter to...

Covaxin looks good, says WHO’s chief scientist: Decision on use likely by August

As Bharat Biotech’s Covid-19 vaccine, Covaxin awaits World Health Organisation’s (WHO) approval, its’ chief scientist Dr. Soumya Swaminathan said the Phase-3 trial data of...

Covaxin over Pfizer by Brazil and its enemies are are working up a storm

Brazil’s health ministry, in February, signed an agreement to purchase 20 million doses of the Covaxin vaccine manufactured by India’s Bharat Biotech. The agreement drew...

Boost for Covaxin’s pending approval: Bharat Biotech to meet WHO today

Bharat Biotech, manufacturer of India's homegrown vaccine against Covid-19 Covaxin, would attend a pre-submission meeting with the World Health Organization (WHO) today.  Earlier on June...

Covaxin has 77.3% efficacy: Phase 3 trials data

Bharat Biotech have announced that the indigenously developed Covid-19 vaccine Covaxin has showed a 77.3 per cent efficacy in its phase 3 trials. The company...

Bharat Biotech to submit Covaxin phase-3 trial data to WHO by June 23

India's indigenous Covid vaccine Covaxin has submitted its phase-3 clinical trial data to World Health Organization (WHO) for its authorization.  According to a report,...

Voices

163 POSTS0 COMMENTS
115 POSTS0 COMMENTS
Support Us
Contribute to see NewsBred grow. And rejoice that your input has made it possible.